Page last updated: 2024-10-24

bupivacaine and Idiopathic Parkinson Disease

bupivacaine has been researched along with Idiopathic Parkinson Disease in 2 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herschman, Z1
Herschman, Y1
Furuya, R1
Hirai, A1
Andoh, T1
Kudoh, I1
Okumura, F1

Other Studies

2 other studies available for bupivacaine and Idiopathic Parkinson Disease

ArticleYear
An alternative treatment for Parkinson's disease.
    The Israel Medical Association journal : IMAJ, 2007, Volume: 9, Issue:3

    Topics: Aged, 80 and over; Bupivacaine; Dopamine; Drug Therapy, Combination; Female; Humans; Medroxyprogeste

2007
Successful perioperative management of a patient with Parkinson's disease by enteral levodopa administration under propofol anesthesia.
    Anesthesiology, 1998, Volume: 89, Issue:1

    Topics: Aged; Anesthetics, Intravenous; Anesthetics, Local; Antiparkinson Agents; Bupivacaine; Colonic Neopl

1998